Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Fey

Showing results (81-90 of 161) with videos related to

Pageof 17
Sort By:
Leukemia|November 2, 2007
The hDMP1 tumor suppressor is a new WT1 target in myeloid leukemiasM P Tschan, U Gullberg, D Shan, et al.
British Journal of Haematology|November 25, 1998
Sampling bias and logistical problems of molecular analyses in a clinical leukaemia trial. Swiss Group for Clinical Cancer Research (SAKK)M F Fey, M Blaser, M Wernli, et al.
Blood|April 15, 1995
Interleukin-12 expression in human lymphomas and nonneoplastic lymphoid disordersJ Schwaller, A Tobler, G Niklaus, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|January 1, 1991
[Large cell anaplastic lymphomas in the immunocompromised host]B Borisch, M F Fey, A Tobler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2014
Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapyA D Vidal, G N Thalmann, E Karamitopoulou-Diamantis, et al.
European Journal of Cancer (Oxford, England : 1990)|October 25, 2000
Ovarian cancer. an institutional review of patterns of care, health insurance and prognosisS Balli, M F Fey, W Hänggi, et al.
European Urology|January 1, 1993
Adjuvant chemotherapy after orchiectomy in high-risk patients with clinical stage I non-seminomatous testicular cancerU E Studer, M F Fey, A Calderoni, et al.
Blood|May 1, 1991
Dexamethasone and 1,25-dihydroxyvitamin D3, but not cyclosporine A, inhibit production of granulocyte-macrophage colony-stimulating factor in human fibroblastsA Tobler, H P Marti, C Gimmi, et al.
Blood|October 15, 1993
Constitutive expression of interleukin-8 and its receptor in human myeloid and lymphoid leukemiaA Tobler, B Moser, B Dewald, et al.
Oncogene|January 15, 2008
PU.1 binding to the p53 family of tumor suppressors impairs their transcriptional activityM P Tschan, V A Reddy, A Ress, et al.
Pageof 17

Showing results (81-90 of 161) with videos related to

Sort By:
Pageof 17
Leukemia|November 2, 2007
The hDMP1 tumor suppressor is a new WT1 target in myeloid leukemiasM P Tschan, U Gullberg, D Shan, et al.
British Journal of Haematology|November 25, 1998
Sampling bias and logistical problems of molecular analyses in a clinical leukaemia trial. Swiss Group for Clinical Cancer Research (SAKK)M F Fey, M Blaser, M Wernli, et al.
Blood|April 15, 1995
Interleukin-12 expression in human lymphomas and nonneoplastic lymphoid disordersJ Schwaller, A Tobler, G Niklaus, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|January 1, 1991
[Large cell anaplastic lymphomas in the immunocompromised host]B Borisch, M F Fey, A Tobler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2014
Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapyA D Vidal, G N Thalmann, E Karamitopoulou-Diamantis, et al.
European Journal of Cancer (Oxford, England : 1990)|October 25, 2000
Ovarian cancer. an institutional review of patterns of care, health insurance and prognosisS Balli, M F Fey, W Hänggi, et al.
European Urology|January 1, 1993
Adjuvant chemotherapy after orchiectomy in high-risk patients with clinical stage I non-seminomatous testicular cancerU E Studer, M F Fey, A Calderoni, et al.
Blood|May 1, 1991
Dexamethasone and 1,25-dihydroxyvitamin D3, but not cyclosporine A, inhibit production of granulocyte-macrophage colony-stimulating factor in human fibroblastsA Tobler, H P Marti, C Gimmi, et al.
Blood|October 15, 1993
Constitutive expression of interleukin-8 and its receptor in human myeloid and lymphoid leukemiaA Tobler, B Moser, B Dewald, et al.
Oncogene|January 15, 2008
PU.1 binding to the p53 family of tumor suppressors impairs their transcriptional activityM P Tschan, V A Reddy, A Ress, et al.
Pageof 17